Fulvestrant

Large-volume IM injections: 
A review of best practices

Large-volume IM injections: 
A review of best practices

Intramuscular injections offer improved treatment adherence, ease in 
monitoring of adverse effects, and multiple administration sites.

Higher fulvestrant doses prolonged survival in patients with advanced breast cancer

Increasing the dose of fulvestrant from 250 mg to 500 mg improved median overall survival in women with locally advanced or metastatic estrogen receptor-positive breast cancer, according to updated data from the CONFIRM trial.

Alternate dosing regimens for estrogen receptor antagonist

Alternate dosing regimens for estrogen receptor antagonist

By

Studies show that alternate dosages of fulvestrant may be efficacious, and adverse effects are similar in all regimens.

FDA-Approved Drugs Treat and Prevent Cervical Cancer in Mice

By

Two FDA-approved drugs may be as effective in treating cervical cancer in human cells as they are in mice, say researchers at the University of Wisconsin-Madison School of Medicine and Public Health.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs